Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Dermatological Research
Published in: Archives of Dermatological Research 3/2014

01-04-2014 | Original Paper

Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument

Authors: Gloria Sanclemente, Jorge-Luis Acosta, Maria-Eulalia Tamayo, Xavier Bonfill, Pablo Alonso-Coello

Published in: Archives of Dermatological Research | Issue 3/2014

Login to get access

Abstract

A significant number of clinical practice guidelines (CPGs) about the treatment of acne vulgaris in adolescents and adults have been published worldwide. However, little is known about the quality of CPGs in this field. The aim of this study was to appraise the methodological quality of published acne vulgaris CPGs. We performed a systematic review of published CPGs on acne vulgaris therapy from July 2002 to July 2012. Three reviewers independently assessed each CPG using the AGREE II instrument. A standardized score was calculated for each of the six domains. Our search strategy identified 103 citations but just six met our inclusion criteria. Agreement among reviewers was very good: 0.981. The domains that scored better were: “scope and purpose” and “clarity and presentation”. Those that scored worse were “stakeholder involvement”, “rigor of development”, and “applicability”. The European and the Malaysian CPGs were the only recommended with no further modifications. In addition, the Mexican, Colombian and the United States guidelines were recommended with provisos, with lower scores regarding stakeholder involvement, rigor of development and applicability. Only two guidelines clearly reported outcome measures for evaluating efficacy or included quality of life outcomes. CPGs varied regarding the consideration of light/laser therapy or consideration of complementary/alternative medicines. None of them included cost considerations of drugs such as systemic isotretinoin. In conclusion, published acne vulgaris CPGs for acne therapy vary in quality with a clear need to improve their methodological rigor. This could be achieved with the adherence to current CPGs development standards.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Alonso-Coello P, Irfan A, Solà I, Gich I, Delgado-Noguera M, Rigau D, Tort S, Bonfill X, Burgers J, Schunemann H (2010) The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 19:e58PubMed
4.
Alonso P, Bonfill X (2007) Guías de práctica clínica (II): búsqueda y valoración crítica. Radiologia 49:23–27PubMedCrossRef
5.
Archer CB, Cohen SN, Baron SE, British Association of Dermatologists and Royal College of General Practitioners. (2012) Guidance on the diagnosis and clinical management of acne. Clin Exp Dermatol 37 Suppl 1:1–6
6.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L, Consortium ANS (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63:1308–1311
7.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B,Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. (2010) AGREE II: advancing guideline development,reporting, and evaluation in health care. Prev Med 51:421–424
8.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Graham ID, Hanna SE, Makarski J, Consortium ANS (2010) Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ 182:1045–1052PubMedCentralPubMedCrossRef
9.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J, Consortium ANS (2010) Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ 182:E472–E478PubMedCentralPubMedCrossRef
10.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium.(2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182: E839–842
11.
12.
Dréno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H, Acne EEGoOAi (2004) European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 14:391–399PubMed
13.
Dréno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, Layton A (2006) An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 16:565–571PubMed
14.
Francke AL, Smit MC, de Veer AJ, Mistiaen P (2008) Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 8:38PubMedCentralPubMedCrossRef
15.
Garcia-Gutierrez JF, Bravo-toledo R (2001) Guias de practica clinica en internet. Aten Primaria 28:74–79PubMedCrossRef
16.
Goodfield MJ, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD (2010) Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010. Br J Dermatol 162:1172–1179PubMedCrossRef
17.
Grilli R, Magrini N, Penna A, Mura G, Liberati A (2000) Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 355:103–106PubMedCrossRef
18.
GUIPCAR Group (2001) Clinical Practice Guideline for the Management of Rheumatoid Arthritis in Spain. Spanish Society of Rheumatology. Madrid, pp: 301
19.
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, Group GW (2008) What is “quality of evidence” and why is it important to clinicians? BMJ 336:995–998PubMedCentralPubMedCrossRef
20.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, Group GW (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926PubMedCentralPubMedCrossRef
21.
Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter AO (1997) Canadian physicians’ attitudes about and preferences regarding clinical practice guidelines. CMAJ 156:1715–1723PubMedCentralPubMed
22.
Hoomans T, Evers SM, Ament AJ, Hübben MW, van der Weijden T, Grimshaw JM, Severens JL (2007) The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health 10:305–316PubMedCrossRef
23.
24.
Institute of Medicine (1990) Clinical Practice Guidelines: Directions for a New Program. National Academy Press, Washington DC
25.
Institute of Medicine (2011) Clinical Practice Guidelines We Can Trust. National Academy Press, Washington DC
26.
Kalla AA, Stanwix A, Gotlieb D, Asherson RA, Mody GM (2003) Rheumatoid arthritis: clinical guideline 2003. S Afr Med J 93:991–1012PubMed
27.
28.
Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP (2012) Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin 30:99–106 Viii–ixPubMedCrossRef
29.
Kramer MS, Feinstein AR (1981) Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 29:111–123PubMedCrossRef
30.
Kubba R, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M, Dhar S, Criton S, Fernandez R, Kanwar AJ, Khopkar U, Kohli M, Kuriyipe VP, Lahiri K, Madnani N, Parikh D, Pujara S, Rajababu KK, Sacchidanand S, Sharma VK, Thomas J, (IAA) IAA (2009) Acne in India: guidelines for management—IAA consensus document. Indian J Dermatol Venereol Leprol 75(Suppl 1):1–62PubMed
31.
Kung J, Miller RR, Mackowiak PA (2012) Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any progress. Arch Intern Med 172:1628–1633PubMedCrossRef
32.
Ledingham J, Deighton C, British Society for Rheumatology Standards GiaAWG (2005) Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44:157–163
33.
Malaysia Ministry of Health, Dermatological Society of Malaysia, Academy of Medicine Malaysia (2012) Clinical practice guidelines: Management of acne. http://​www.​moh.​gov.​my. Accessed July 2012
34.
Mikkelsen CS, Hansen SR, Kroon S (2011) Local treatment of acne. Tidsskr Nor Laegeforen 131:33–34PubMedCrossRef
35.
Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, Fluhr J, Gieler U, Hartwig R, Meigel EM, Möller S, Ochsendorf F, Podda M, Rabe T, Rzany B, Sammain A, Schink S, Zouboulis CC, Gollnick H, (BVDD) GSoDDatAoGD (2010) S2 k-guideline for therapy of acne. J Dtsch Dermatol Ges 8(Suppl 2):s1–s59PubMed
36.
Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivković MV, Zouboulis CC, Gollnick H, Forum ED (2012) European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 26(Suppl 1):1–29PubMedCrossRef
37.
Nast A, Rosumeck S, Sammain A, Sporbeck B, Rzany B (2012) Methods report on the development of the European S3 guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 26(Suppl 1):e1–e41PubMedCrossRef
38.
National Institute for Clinical Excellence (2002) Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis: technology appraisal guidance no. http://​www.​nice.​org.​uk. Accessed July 2012
39.
Niessen LW, Grijseels E, Koopmanschap M, Rutten F, Health DMo (2007) Economic analysis for clinical practice–the case of 31 national consensus guidelines in the Netherlands. J Eval Clin Pract 13:68–78PubMedCrossRef
40.
Orozco B, Campo ME, Anaya LA, Atuesta J, Ávila MJ, Balcázar LF et al (2011) Guías colombianas para el manejo del acné: una revisión basada en la evidencia por el Grupo Colombiano de Estudio en Acné. Rev Asoc Colomb Dermatol 19:129–158
41.
Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O’Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC (2004) Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 364:2188–2195PubMedCrossRef
42.
43.
Poitras S, Rossignol M, Avouac J, Avouac B, Cedraschi C, Nordin M, Rousseaux C, Rozenberg S, Savarieau B, Thoumie P, Valat JP, Vignon E, Hilliquin P (2010) Management recommendations for knee osteoarthritis: how usable are they? Jt Bone Spine 77:458–465CrossRef
44.
Poolman RW, Verheyen CC, Kerkhoffs GM, Bhandari M, Schünemann HJ, Group IE-BOSW (2009) From evidence to action: Understanding clinical practice guidelines. Acta Orthop 80:113–118
45.
46.
Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P, BoTotGI Network (2012) Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med 156:525–531PubMedCrossRef
47.
Ramos-e-Silva M, Carneiro SC (2009) Acne vulgaris: review and guidelines. Dermatol Nurs 21:63–68 quiz 69PubMed
48.
49.
Shaneyfelt TM, Mayo-Smith MF, Rothwangl J (1999) Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281:1900–1905PubMedCrossRef
50.
Sinclair W, Jordaan HF, Global Alliance to Improve Outcomes in Acne (2005) Acne Guideline 2005 Update. S Afr Med J 95:881–892
51.
52.
Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, Thiboutot DM, Van Voorhees AS, Beutner KA, Sieck CK, Bhushan R, Association AAoDAAoD (2007) Guidelines of care for acne vulgaris management. J Am Acad Dermatol 56:651–663PubMedCrossRef
53.
Tan JK, Wolfe BJ, Bulatovic R, Jones EB, Lo AY (2010) Critical appraisal of quality of clinical practice guidelines for treatment of psoriasis vulgaris, 2006–2009. J Invest Dermatol 130:2389–2395PubMedCrossRef
54.
Torres V, Gollnick H, Campo MH, de-Castro L, Cordero A, Talarico S, Gomez M et al (2008) Reporte final de la Primera Reunión de la Alianza Global para mejorar el Tratamiento del Acné (Global Alliance to Improve Outcomes in Acne). Capítulo Latinoamérica. “GALA” Cartagena, Colombia. Mayo 6–7, 2007. Dermatología Rev Mex 52:S1–S40
55.
Vale L, Thomas R, MacLennan G, Grimshaw J (2007) Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ 8:111–121PubMedCrossRef
56.
Wimpenny P, van Zelm R (2007) Appraising and comparing pressure ulcer guidelines. Worldviews Evid Based Nurs 4:40–50PubMedCrossRef
57.
Zaenglein AL, Thiboutot DM (2006) Expert committee recommendations for acne management. Pediatrics 118:1188–1199PubMedCrossRef
Metadata
Title
Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument
Authors
Gloria Sanclemente
Jorge-Luis Acosta
Maria-Eulalia Tamayo
Xavier Bonfill
Pablo Alonso-Coello
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 3/2014
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-013-1394-x

Other articles of this Issue 3/2014

Archives of Dermatological Research 3/2014 Go to the issue

Original Paper

Willingness to pay and quality of life in patients with atopic dermatitis

Letter to the Editor

Frosch′ surface microscopy score for the assessment of steroid-induced atrophy

Concise Communication

IL-33 is regulated by TNF-α in normal and psoriatic skin

Original Paper

Analysis of manganese superoxide dismutase (MnSOD Ala-9Val) and glutathione peroxidase (GPx1 Pro 198 Leu) gene polymorphisms in psoriasis

Original Paper

Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk

Original Paper

Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome